Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 149 (miR-149) is a small, non-coding RNA (microRNA) located at chromosome 2q37.3 within the first intron of the glypican 1 (GPC1) gene, and it post-transcriptionally regulates gene expression by binding to complementary sequences in the 3′-UTR of target mRNAs, leading to their degradation or translational silencing. miR-149 generates two mature strands (miR-149-5p and miR-149-3p), both of which can have distinct and sometimes opposing functions in different cellular contexts. miR-149 is implicated in the regulation of cell proliferation, apoptosis, migration, invasion, EMT, and angiogenesis, operating within major pathways such as PI3K/AKT, MAPK, and T/B cell receptor signaling. Dysregulation of miR-149 contributes to cancer initiation, progression, metastasis, chemoresistance, and possibly other diseases, serving as both a tumor suppressor and (less commonly) oncogene depending on the setting. Its role as a biomarker and potential as a therapeutic target in oncology are under active investigation, though drug development is complicated by its tissue- and context-specific dual actions and broad regulatory capacity.
Binds to 3′-untranslated region of target mRNAs, causing translational repression or mRNA degradation via the RNA-induced silencing complex (RISC) Modulates expression of oncogenes and tumor suppressors (e.g., targets AKT1, FASLG, FGF2, PTEN, mTOR, PI3K, FGFR1)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 149 (miR-149).